When
Thursday November 10, 2016
11:30 AM to 1:00 PM EST
Contact
Clinician Education DepartmentClinical Directors Network, Inc. (CDN)
New York NY 10018
212-382-0699 Ext 243
eLearning2@CDNetwork.org
Benzodiazepines:
Overdose Trends and Judicious Prescribing Guidelines - The New York City Experience
Speakers:
Jessica Kattan, MD, MPH
Director - Primary Care Integration Unit
Bureau of Alcohol and Drug Use Prevention, Care and Treatment
New York City Department of Health and Mental Hygiene
Denise Paone, EdD
Senior Director of Research and Surveillance, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Krishika Graham, MD
Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene
Director - Primary Care Integration Unit
Bureau of Alcohol and Drug Use Prevention, Care and Treatment
New York City Department of Health and Mental Hygiene
Bureau of Alcohol and Drug Use Prevention, Care and Treatment
New York City Department of Health and Mental Hygiene
Denise Paone, EdD
Senior Director of Research and Surveillance, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Krishika Graham, MD
Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene
Senior Director of Research and Surveillance, Bureau of Alcohol and Drug Use Prevention, Care and Treatment, New York City Department of Health and Mental Hygiene
Krishika Graham, MD
Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene
Krishika Graham, MD
Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene
Public Health/Preventive Medicine Resident, New York City Department of Health and Mental Hygiene
A Live Webcast Sponsored by:
Opioid Post-Marketing Requirements Consortium (OPC)/Campbell Alliance (Purdue Pharma, LP; Actavis; Endo Pharmaceuticals; Janssen Pharmaceuticals; Mallinckrodt, LLC; Pfizer; Rhodes Pharmaceuticals, LP; Roxane Laboratories; and Zogenix), Clinical Directors Network, Inc.(CDN), N2 PBRN Virtual Training Series (AHRQ, Grant No. 1P30-HS-021667)
This webcast is pending for up to 1.5 Prescribed credits by the American Academy of Family Physicians (AAFP)